Prognostic parameters for acute esophagus toxicity in intensity modulated radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer.

[1]  Jan-Jakob Sonke,et al.  Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Jan-Jakob Sonke,et al.  Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy. , 2012, International journal of radiation oncology, biology, physics.

[3]  B. Bergman,et al.  Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  V. Bar-ad,et al.  Esophagitis, treatment-related toxicity in non-small cell lung cancer. , 2012, Reviews on recent clinical trials.

[5]  Jan-Jakob Sonke,et al.  In aqua vivo EPID dosimetry. , 2011, Medical physics.

[6]  M. Othus,et al.  Esophagus in-field: a new predictor for esophagitis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Jose Belderbos,et al.  Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Joseph O. Deasy,et al.  Radiation dose-volume effects in the esophagus. , 2010, International journal of radiation oncology, biology, physics.

[9]  Shipeng Yu,et al.  Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[10]  B. Yaremko,et al.  Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Jan-Jakob Sonke,et al.  Kilo-voltage cone-beam computed tomography setup measurements for lung cancer patients; first clinical results and comparison with electronic portal-imaging device. , 2007, International journal of radiation oncology, biology, physics.

[12]  G. Giaccone,et al.  Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). , 2007, European journal of cancer.

[13]  R. Mohan,et al.  Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[14]  R. T. Ten Haken,et al.  Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Jose Belderbos,et al.  Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Lawrence B Marks,et al.  Dosimetric and clinical predictors for radiation-induced esophageal injury. , 2005, International journal of radiation oncology, biology, physics.

[17]  Wen-BoQiao,et al.  Clinical and dosimetric factors of radiation-induced esophageal injury： Radiation-induced esophageal toxicity , 2005 .

[18]  Jeffrey D Bradley,et al.  Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. , 2003, International journal of radiation oncology, biology, physics.

[19]  W. Curran,et al.  Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. , 2000, International journal of radiation oncology, biology, physics.

[20]  H. Choy,et al.  Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. , 1999, Seminars in radiation oncology.

[21]  J. Holland,et al.  Cross-cultural differences in the care of patients with cancer. A review. , 1993, General hospital psychiatry.

[22]  H. Bartelink,et al.  Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.

[23]  W. Landuyt,et al.  Effect of age on the radiation-induced repopulation in mouse lip mucosa. , 1991, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[24]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[25]  H. Bartelink,et al.  Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.